EuroPCR 2025

20 May 2025

Stents, scaffolds and DCB Other coronary interventions

The future is now: QFR and RMS to optimise coronary artery disease patient management

Sponsored by Biotronik and Medis Medical Imaging

Anchorperson: H. Garcia

Spokesperson: J. Wykrzykowska

SHOW MORE

Summary

See how next-generation technologies are reshaping coronary artery disease treatment in this EuroPCR 2025 session. Learn how QFR is being used to plan PCI and evaluate results, and discover new insights into RMS technology—offering a potential leap beyond traditional drug-eluting stents. From practical case experience to in-depth analysis using angio and CT imaging, each presentation helps you better understand how data-driven strategies can improve decision-making and patient outcomes.

Learning Objectives

To learn the latest updates on QFR from a clinical perspective
To learn out the RMS technology and potential benefits over drug-eluting stent
To learn the role of angio and CT-based analyses in PCI planning and guidance

Yoshinobu Onuma

Speaker

QFR for planning and evaluation PCI results

Download presentation

Speaker

Practical clinical experience with next generation solutions

Download presentation

Speaker

Freesolve, a step beyond the drug-eluting stent plateau?

Download presentation

Speaker

Beyond treatment options, what we learn from angio and CT-based analyses

Download presentation

Joanna Wykrzykowska

Speaker

J. Wykrzykowska

Session evaluation and key learnings

Download presentation